- MGTX +2.82%
Analyst Forecasts For MeiraGTx Holdings plc (NASDAQ:MGTX) Are Surging Higher
Yahoo Finance · 2 weeks ago
Search results
- 5.28Add to watchlist+0.14 (+2.82%)At close: Fri. May 24, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed
- Open5.21High5.36Low5.03
- Mkt Cap339.86MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close5.1452 Wk. Low3.4952 Wk. High8.35
Top storiesRelated stocks
MeiraGTx's (MGTX) shares surge on the sale of rights for a rare ocular disease gene therapy for up to $ 415 million. This funding helps MGTX extend its cash runway into mid-2026.
Get the latest MeiraGTx Holdings PLC (MGTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
MeiraGTx is a clinical-stage gene therapy company focused on developing potentially curative treatments for patients living with serious diseases. We currently have six programs in clinical development including four ocular indications, a salivary gland condition, and a Parkinson’s disease program.
12 days ago - GlobeNewsWire. MeiraGTx to Participate in Upcoming Investor Conferences. LONDON and NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D... 27 days ago - GlobeNewsWire.
Options. Advanced Charting. News MeiraGTx Holdings PLC. No significant news for in the past two years. ? Key Stock Data. P/E Ratio (TTM) N/A. EPS (TTM) $-1.28. Market Cap. $355.62 M. Shares...
MeiraGTx Holdings plc Ordinary Shares (MGTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Simply Wall St. MeiraGTx Holdings First Quarter 2024 Earnings: US$0.32 loss per share (vs US$0.62 loss in 1Q 2023) Find the latest MeiraGTx Holdings plc (MGTX) stock quote, history, news and...
